Latest news

Roche offers $50 billion to US pharma production in response to the tariff threat

Roche, the drugmaker giant, announced its interest in investing $50 billion over five years in new and existing facilities...

Biolinq Secures $100 Million to Advance Glucose Biosensor and Expand Commercialization Plans

Biolinq has announced the successful closure of a $100 million venture capital investment round aimed at finalizing the development...

VelaVigo Bio Strikes Second Major Licensing Agreement, Transfers Bispecific Rights to Ollin Biosciences

In a continued series of strategic moves, VelaVigo Bio, a biotechnology firm based in Shanghai, has finalized its second...

Click Therapeutics Gains FDA Clearance for First Prescription Digital Migraine Prevention Tool

Click Therapeutics has secured a notable regulatory milestone with the U.S. Food and Drug Administration granting authorization for CT-132,...

Life Sciences Voice Top Five Newsletter

Welcome to this week’s edition of the Life Sciences...

GSK’s Blenrep Returns with U.K. Approval for Multiple Myeloma Combination Therapies

GSK has received regulatory approval in the United Kingdom...

Lilly’s Orforglipron Demonstrates Semaglutide-Like Efficacy in Phase 3 Type 2 Diabetes Trial

Eli Lilly’s oral GLP-1 receptor agonist orforglipron has met its primary efficacy endpoint in a Phase 3 trial, showing...

Sanofi Deepens Autoimmune Push with $1.8B AI Biotech Deal

Sanofi’s ambition to become a dominant force in immunology continues to take shape, as the French pharmaceutical giant signs...

Merck Signs $493M Agreement to Use Cyprumed’s Oral Peptide Platform

Merck & Co. is taking a significant step toward transforming its peptide therapies into convenient oral tablets through a...

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical...

Pfizer Decides Against Pursuing Lead Obesity Asset Amid Liver Safety Concerns

Pfizer said that it had discovered a possible instance of medication-induced liver impairment and, as a result, would no...

Vanda Challenges FDA Over Limits on Off-Label Drug Communication

Vanda Pharmaceuticals is pushing back against the U.S. Food and Drug Administration (FDA), accusing the agency of stifling the...

Life Sciences Voice Top Five Newsletter

Welcome to this week’s edition of the Life Sciences Voice Top Five Newsletter, your go-to source for the latest...

Activist investor Elliott Management asks for new board and CEO to reapply

Before the splitting of GlaxoSmithKline’s consumer healthcare sector next year, Elliot Management, an activist US investor

Fate, Century, and TCR2 Therapeutics make major cuts to staff and research

Fate, Century, and TCR2 Therapeutics have planned...

Popular

Most popular life news you must read today

A Patient Centric Approach to Clinical Research is Key for Product Development

Ensuring a patient centric approach during clinical...

NRx Pharma’s ZYESAMI™ approved for emergency use Covid critical care in Georgia

As of July 27, a global biopharmaceutical company, NRx Pharmaceuticals, has announced that the Prime Minister of the Nation of Georgia

Commercial

Biolinq Secures $100 Million to Advance Glucose Biosensor and Expand Commercialization Plans

Biolinq has announced the successful closure of a $100 million venture capital investment round aimed at finalizing the development...

Sanofi Deepens Autoimmune Push with $1.8B AI Biotech Deal

Sanofi’s ambition to become a dominant force in immunology continues to take shape, as the French pharmaceutical giant signs...

Merck Signs $493M Agreement to Use Cyprumed’s Oral Peptide Platform

Merck & Co. is taking a significant step toward transforming its peptide therapies into convenient oral tablets through a...

OPM Cuts Staff, Executive Wages in Wake of Servier Exit

The French biotech company Oncodesign Precision Medicine has been forced to tighten its purse strings as a result of...

Eli Lilly provides a $1.4 billion gene therapy contract to struggling Sangamo

Through its licensing deal with Eli Lilly, Sangamo Therapeutics received $18 million to let the pharma use its neurotropic...

Opko & Entera Enter Partnership to Develop Obesity Pill

Opko Health and Entera Bio have formally announced their collaboration as the biopharmaceutical companies seek to advance the first...

Information Technology

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...

Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient

Neuralink, founded by Elon Musk, revealed that it has placed its device in the...

Regulatory

Click Therapeutics Gains FDA Clearance for First Prescription Digital Migraine Prevention Tool

Click Therapeutics has secured a notable regulatory milestone with...

Click Therapeutics Gains FDA Clearance for First Prescription Digital Migraine Prevention Tool

Click Therapeutics has secured a notable regulatory milestone with...

Chinese CRO GemPharmatech Expands in San Diego as FDA Reevaluates Animal Testing Requirements

The Chinese contract research organization (CRO) GemPharmatech continues to...

Research & Development

BioMed X Launches XBridge Program to Support U.S. Reacsearchers Amid NIH Funding Cuts

As research institutions throughout the United States grapple with increasing instability, many are being...

Taiho spends $400 million with a Swiss partner to “turbocharge” three ADCs to the clinic

Taiho Pharmaceutical has paid Otsuka $400 million in upfront purchase of the Araris Biotech...

Élancé Therapeutics Joins the Race to Develop Next-Generation Obesity Therapies

China-based Harbour BioMed has recently announced the establishment of a new biotechnology company, Élancé...

Roche Comes Out With Novel ‘Sequencing-By-Expansion’ Approach

Roche has proposed a fresh kind of genetic analysis. This process, which the company...

Market Access

Roche offers $50 billion to US pharma production in response to the tariff threat

Roche, the drugmaker giant, announced its interest in investing $50 billion over five years...

Chinese CRO GemPharmatech Expands in San Diego as FDA Reevaluates Animal Testing Requirements

The Chinese contract research organization (CRO) GemPharmatech continues to increase its U.S. facilities by...

Merck develops $1B Gardasil production plant in North Carolina

The Durham complex of Merck now operates a new $1 billion, massive 225,000-square-foot bulk...

Merck Increases Vaccine Production With New $1B Manufacturing Facility in North Carolina

Merck has inaugurated a fresh $1 billion, 225,000-square-foot manufacturing site at its extensive compound...

Rovi’s Expansion in Pharmaceutical Production with Moderna

The Laboratorios Farmacéuticos Rovi and Moderna partnership...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Roche offers $50 billion to US pharma production in response to the tariff threat

Roche, the drugmaker giant, announced its interest in investing...

Chinese CRO GemPharmatech Expands in San Diego as FDA Reevaluates Animal Testing Requirements

The Chinese contract research organization (CRO) GemPharmatech continues to...